Treatment of Urinary Tract Infections in Infants
For infants 2-24 months with uncomplicated UTI, treat with oral antibiotics for 7-14 days using a cephalosporin, amoxicillin-clavulanate, or trimethoprim-sulfamethoxazole based on local resistance patterns, reserving parenteral therapy only for toxic-appearing infants or those unable to retain oral intake. 1
Route of Administration
Oral and parenteral routes are equally efficacious for initiating treatment in infants with UTI 1. The decision should be based on practical considerations:
- Most infants can be treated orally from the start - only 1% of febrile infants in one study were too ill for oral therapy 1
- Use parenteral therapy when:
- Infant appears "toxic" or severely ill
- Unable to retain oral fluids or medications
- Compliance with obtaining/administering oral antibiotics is uncertain 1
For infants started on IV therapy, transition to oral antibiotics once clinically improved (typically 24-48 hours) and able to retain oral intake 1
Antibiotic Selection
Oral Options (with dosing):
- Cephalosporins (preferred based on local resistance):
- Cefixime: 8 mg/kg/day in 1 dose
- Cefpodoxime: 10 mg/kg/day in 2 doses
- Cefprozil: 30 mg/kg/day in 2 doses
- Cefuroxime axetil: 20-30 mg/kg/day in 2 doses
- Cephalexin: 50-100 mg/kg/day in 4 doses
- Amoxicillin-clavulanate: 20-40 mg/kg/day in 3 doses
- Trimethoprim-sulfamethoxazole: 6-12 mg/kg trimethoprim + 30-60 mg/kg sulfamethoxazole per day in 2 doses 1
Parenteral Options (with dosing):
- Ceftriaxone: 75 mg/kg every 24 hours (preferred for IV therapy based on 2024 guidelines) 2
- Cefotaxime: 150 mg/kg/day divided every 6-8 hours
- Gentamicin: 7.5 mg/kg/day divided every 8 hours
- Tobramycin: 5 mg/kg/day divided every 8 hours 1
Critical Selection Considerations:
Know your local resistance patterns - there is substantial geographic variability in resistance to trimethoprim-sulfamethoxazole and cephalexin 1. Adjust empiric choice based on local antibiograms and modify based on culture sensitivities.
Avoid nitrofurantoin in febrile infants - it achieves inadequate blood and parenchymal concentrations to treat pyelonephritis or urosepsis, despite adequate urinary levels 1. This is a common pitfall.
Duration of Therapy
Treat for 7-14 days total regardless of whether started orally or parenterally 1. The evidence does not support a single optimal duration within this range, but:
- Minimum 7 days is essential - shorter courses (1-3 days) are inferior 1
- Recent evidence suggests 5-day courses may be reasonable for uncomplicated febrile UTI in children showing clinical improvement, though this remains somewhat controversial 3
- Count total days of therapy, not just oral days if transitioned from IV
Special Populations
Neonates (0-28 days):
- Require hospitalization and parenteral therapy initially 4
- Use amoxicillin plus cefotaxime (not ceftriaxone due to bilirubin concerns)
- After 3-4 days of good response, can transition to oral to complete 14 days total 4
- Must exclude meningitis before shortening IV course or transitioning to oral 5
Young infants (29-90 days):
- If clinically well: can manage as outpatient with daily ceftriaxone or gentamicin until afebrile 24 hours, then oral to complete 14 days 4
- If ill-appearing: hospitalize for IV therapy, transition when improved 4
- Meningitis exclusion is essential before oral transition, particularly in this age group 5
Common Pitfalls to Avoid
- Using nitrofurantoin for febrile UTI - inadequate tissue penetration
- Ignoring local resistance patterns - empiric choices must reflect your community's antibiogram
- Treating for <7 days - insufficient for febrile UTI
- Assuming all infants need IV therapy - oral is equally effective for most
- Failing to exclude meningitis in neonates before shortening IV course 5
Imaging Considerations
All febrile infants with UTI should undergo renal and bladder ultrasonography to detect anatomic abnormalities, though timing can be flexible - urgent imaging (within 2 days) is only needed if severely ill or not improving 1